/Companies

ExpressCells

Philadelphia, US · Founded 2018 · Delaware corporation · 1 known investors

Find your way into ExpressCells

Founders & leadership

MH
Matthew HandelExecutive

Board

TA
Tom AndersonBoard director
SB
Sajad BilgramiBoard director
WD
Wendy DiCiccoBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$1.8M disclosed across 2 rounds · 2019–2020

▶$590.5KraisedApr 2021 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tom AndersonDirector
  • Matthew HandelExecutive Officer, Director
  • Wendy DiCiccoDirector
  • Sajad BilgramiDirector
Offering amount
$650K
Amount sold
$590.5K
First sale
Oct 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedSep 2019 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew HandelExecutive Officer, Director
Offering amount
$1.2M
Amount sold
$1.2M
First sale
Jun 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are ExpressCells's investors?
ExpressCells's investors include Rowan Innovation Venture Fund.
How much funding has ExpressCells raised?
ExpressCells has disclosed $1.8M raised across 2 rounds.
Where is ExpressCells headquartered?
ExpressCells is headquartered in Philadelphia, US.